Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on: December 25,2023

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on:December 25,2023

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns

Updated on: December 20,2023

Most incidentally found adrenal tumors are nonfunctioning, regardless of patient age

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA cross-sectional study of more than 25,000 adults has found that with increased screening, the prevalence of adrenal tumors in an uns

Updated on:December 20,2023

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024

Faster liquid biopsies could replace invasive tissue cancer detections

by Zeina Kayyali,Purdue UniversityCredit: CC0 Public DomainTests to determine if you have cancer can be frightening, uncomfortable and time-consuming. Now, Purdue University researchers have dev

Updated on: December 18,2023

Faster liquid biopsies could replace invasive tissue cancer detections

by Zeina Kayyali,Purdue UniversityCredit: CC0 Public DomainTests to determine if you have cancer can be frightening, uncomfortable and time-consuming. Now, Purdue University researchers have dev

Updated on:December 18,2023

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on: December 25,2023

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on:December 25,2023

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on: March 30,2024

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on:March 30,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on: January 23,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on:January 23,2024

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

Updated on: March 25,2024

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

Updated on:March 25,2024

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on: April 18,2024

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on:April 18,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on: January 04,2024

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on:January 04,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on: May 14,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on:May 14,2024